264
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Different Systemic Inflammatory Markers in Predicting Clinical Outcomes with Syntax Score in Patients with Non-ST Segment Elevation Myocardial Infarction: A Retrospective Study

, , , , & ORCID Icon
Pages 2595-2607 | Received 22 Mar 2023, Accepted 09 Jun 2023, Published online: 19 Jun 2023

References

  • Tan NS, Goodman SG, Yan RT, et al. Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2013;166(2):290–297. doi:10.1016/j.ahj.2013.04.010
  • Cheng CC, Yu FH, Ko PS, et al. Prognostic analysis of patients with acute myocardial infarction undergoing implantation of different stents for the first time. J Clin Med. 2021;10(21):5093. doi:10.3390/jcm10215093
  • Kundu A, Sardar P, O’Day K, et al. SYNTAX score and outcomes of coronary revascularization in diabetic patients. Curr Cardiol Rep. 2018;20(5):28. doi:10.1007/s11886-018-0971-1
  • Hayıroğlu Mİ, Keskin M, Uzun AO, et al. Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging. 2018;34(3):329–336. doi:10.1007/s10554-017-1241-9
  • De Servi S, Crimi G, Calabrò P, et al. Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. EuroIntervention. 2016;12(3):312–318. doi:10.4244/EIJV12I3A51
  • Rafaeli IR, Kireeva AI, Tsereteli NV, et al. The influence of the initial severity of coronary artery lesion (by the Syntax Score) on the midterm prognosis of patients with acute myocardial infarction without ST segment elevation. Kardiologiia. 2022;62(11):19–25. doi:10.18087/cardio.2022.11.n1984
  • Ruparelia N, Choudhury R. Inflammation and atherosclerosis: what is on the horizon? Heart. 2020;106(1):80–85. doi:10.1136/heartjnl-2018-314230
  • Wang H, Liu Z, Shao J, et al. Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications. J Immunol Res. 2020;18:4904217.
  • Thackeray JT, Hupe HC, Wang Y, et al. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J Am Coll Cardiol. 2018;71(3):263–275. doi:10.1016/j.jacc.2017.11.024
  • Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666–682. doi:10.1038/s41569-021-00552-1
  • Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15(8):640–647. doi:10.5152/akd.2014.5565
  • Akboga MK, Canpolat U, Yayla C, et al. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67(1):89–95. doi:10.1177/0003319715583186
  • Uçar FM, Açar B, Gul M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity in asymptomatic low ejection fraction patients. Korean Circ J. 2016;46(6):821–826. doi:10.4070/kcj.2016.46.6.821
  • Wang W, Ren D, Wang CS, et al. Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome. Biomark Med. 2019;13(10):811–820. doi:10.2217/bmm-2018-0346
  • Ren H, Zhao L, Liu Y, et al. The high-sensitivity C-reactive protein to prealbumin ratio predicts adverse cardiovascular events after ST-elevation myocardial infarction. Heart Surg Forum. 2021;24(1):E153–E157. doi:10.1532/hsf.3307
  • Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715–720. doi:10.1097/MCA.0000000000001037
  • Yang Y-L, Wu C-H, Hsu P-F, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
  • Wada H, Dohi T, Miyauchi K, et al. Neutrophil to lymphocyte ratio and long-term cardiovascular outcomes in coronary artery disease patients with low high-sensitivity C-reactive protein level. Int Heart J. 2020;61(3):447–453. doi:10.1536/ihj.19-543
  • Kurtul S, Sarli B, Baktir AO, et al. Neutrophil to lymphocyte ratio predicts SYNTAX score in patients with non-ST segment elevation myocardial infarction. Int Heart J. 2015;56(1):18–21. doi:10.1536/ihj.14-175
  • Agarwal R, Aurora RG, Siswanto BB, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 2022;33(2):137–143. doi:10.1097/MCA.0000000000001040
  • Nilsson L, Wieringa WG, Pundziute G, et al. Neutrophil/Lymphocyte ratio is associated with non-calcified plaque burden in patients with coronary artery disease. PLoS One. 2014;9(9):e108183. doi:10.1371/journal.pone.0108183
  • Nam SH, Kang SG, Song SW. The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a cross-sectional study. Biomed Res Int. 2017;2017:1989417. doi:10.1155/2017/1989417
  • Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol. 2014;114(7):972–978. doi:10.1016/j.amjcard.2014.07.005
  • Li XT, Fang H, Li D, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chin Med J. 2020;133(4):415–423. doi:10.1097/CM9.0000000000000650
  • Qiu Z, Jiang Y, Jiang X, et al. Relationship between platelet to lymphocyte ratio and stable coronary artery disease: meta-analysis of observational studies. Angiology. 2020;71(10):909–915. doi:10.1177/0003319720943810
  • Camaj A, Giustino G, Kocovic N, et al. Effect of elevated C-reactive protein on outcomes after complex percutaneous coronary intervention for angina pectoris. Am J Cardiol. 2022;168:47–54. doi:10.1016/j.amjcard.2021.12.042
  • Çinar T, Hayiroğlu MI, Çiçek V, et al. Predictive value of serum albumin in patients with acute coronary syndrome. Angiology. 2021;72(1):93–94. doi:10.1177/0003319720952293
  • Çağdaş M, Rencüzoğullari I, Karakoyun S, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70(4):361–368. doi:10.1177/0003319717743325
  • Karabağ Y, Çağdaş M, Rencuzogullari I, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32(7):e22457. doi:10.1002/jcla.22457
  • Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130–136. doi:10.1097/MCA.0000000000000768
  • Güney BÇ, Taştan YÖ, Doğantekin B, et al. Predictive value of CAR for In-hospital mortality in patients with COVID-19 pneumonia: a retrospective cohort study. Arch Med Res. 2021;52(5):554–560. doi:10.1016/j.arcmed.2021.02.006
  • Çinier G, Hayıroğlu Mİ, Kolak Z, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51(8):e13550. doi:10.1111/eci.13550
  • Hayıroğlu Mİ, Çınar T, Çinier G, et al. Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers. Biomark Med. 2022;16(5):341–348. doi:10.2217/bmm-2021-0991
  • Çinier G, Hayıroğlu Mİ, Pay L, et al. Prognostic nutritional index as the predictor of long-term mortality among HFrEF patients with ICD. Pacing Clin Electrophysiol. 2021;44(3):490–496. doi:10.1111/pace.14170
  • Çınar T, Hayıroğlu Mİ, Çiçek V, et al. Is prognostic nutritional index a predictive marker for estimating all-cause in-hospital mortality in COVID-19 patients with cardiovascular risk factors? Heart Lung. 2021;50(2):307–312. doi:10.1016/j.hrtlng.2021.01.006
  • Hayıroğlu Mİ, Çınar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
  • Candemir M, Kiziltunç E, Nurkoç S, et al. Relationship between Systemic Immune-Inflammation Index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
  • Tavares F, Moraes PIM, Souza JM, et al. Prognostic role of neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing to pharmaco-invasive strategy. Cardiovasc Revasc Med. 2022;34:99–103. doi:10.1016/j.carrev.2021.01.027
  • Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896–903. doi:10.1093/eurheartj/ehaa1034
  • Dong G, Huang A, Liu L. Platelet-to-lymphocyte ratio and prognosis in STEMI: a meta-analysis. Eur J Clin Invest. 2021;51(3):e13386. doi:10.1111/eci.13386
  • Wang W, Ren D, Wang CS, et al. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Sci Rep. 2019;9(1):11583. doi:10.1038/s41598-019-48189-y
  • Zhao J, Lv H, Yin D, et al. Systemic immune-inflammation index predicts long-term outcomes in patients with three-vessel coronary disease after revascularization: results from a large cohort of 3561 patients. J Inflamm Res. 2022;15:5283–5292. doi:10.2147/JIR.S385990
  • Atum M, Alagöz G. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with retinal artery occlusion. J Ophthalmic Vis Res. 2020;15(2):195–200. doi:10.18502/jovr.v15i2.6737
  • He K, Si L, Pan X, et al. Preoperative Systemic Immune-Inflammation Index (SII) as a superior predictor of long-term survival outcome in patients with stage I-II gastric cancer after radical surgery. Front Oncol. 2022;12:829689. doi:10.3389/fonc.2022.829689